Using genetic programming to classify node positive patients in bladder cancer

GECCO 2006 - Genetic and Evolutionary Computation Conference

Volumn 1, Issue , 2006, Pages 239-246

  Almal, Arpit A ^a   Mitra, Anirban P ^b   Datar, Ram H ^b   Lenehan, Peter F ^a   Fry, David W ^a   Cote, Richard J ^b   Worzel, William P ^a  

^a Genetics Squared Inc   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Bladder cancer; Classification; Feature selection; Genetic Programming; Machine Learning; Nodal staging

Indexed keywords

FEATURE EXTRACTION; GENES; GENETIC ALGORITHMS; LEARNING SYSTEMS;

BLADDER CANCER; GENETIC PROGRAMMING; NODAL STAGING; PROGNOSIS;

TUMORS;

EID: 33750238704     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1145/1143997.1144040     Document Type: Conference Paper

References (59)

1. American Cancer Society. Cancer Facts and Figures 2005. Atlanta: American Cancer Society; 2005
2. Hermanek P, Hutter RVP, Sobin LH, Wagner G, Wittekind CH, eds. TNM Atlas, 4th edn. XX. Springer, Berlin, 1997
3. Epstein JI, Amin MB, Reuter VR, Mostofi FK, The World Health Organization/International Society of Urological Pathology Consensus Classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22, (1998), 1435-48
4. Esrig D, Elmajian D, Groshen S, et al. Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med. 331, (1994), 1259-64
5. Lotan Y, A Gupta, SF Shariat, OS Palapattu, A Vazina, PI Karakiewicz, PJ Bastian, CG Rogers, G Amiel, P Perotte, MP Schoenberg, SP Lerner, AI Sagalowsky. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol, 23,27 (2005),6533-6539
6. Apostolakos MJ, Schuermann WH, Frampton MW, Utell MJ, Willey JC. Measurement of gene expression by multiplex competitive polymerase chain reaction. Anal Biochem. 213, (1993), 277-84
7. Crawford EL, Warner KA, Khuder SA, Zahorchak RJ, Willey JC. Multiplex standardized RT-PCR for expression analysis of many genes in small samples. Biochem Biophys Res Commun. 293, (2002), 509-16
8. RJ Cote and RH Datar, Therapeutic approaches to bladder cancer: identifying targets and mechanisms. Critical Reviews in Oncology-Hematology (Supplemental), 46, (2000), S67-S83.
9. Andre, D. and Koza, J.R, A parallel implementation of genetic programming that achieves super-linear performance. In Hamid R. Arabnia, ed., Proceedings of the International Conference on Parallel and Distributed Processing Techniques and Applications, volume III, (Sunnyvale, 9-11 August 1996) 1163-1174
10. Koza, J.R, Genetic Programming: On the Programming of Computers by Means of Natural Selection, MIT Press, Cambridge, MA, 1992
11. Brameier M., Haan J., Krings A., MacCallum R, Automatic discovery of cross-family sequence features associated with protein function BMC Bioinformatics (2006), 7:16
12. Driscoll JA, Worzel WP, MacLean CD., Classification of Gene Expression Data with Genetic Programming. In Genetic Programming Theory and Practice. R Riolo, WP Worzel (eds.), Springer Science+Business Media, Inc., NY, pp: 25-42, 2004
13. J.H. Hong, S.B. Cho. Cancer Prediction Using Diversity-Based Ensemble Genetic Programming. Lecture Notes in Computer Science 3558 (2005) 294-304
14. Langdon W., Buxton B., Genetic Programming for Mining DNA Chip Data from Cancer Patients. Genetic Programming and Evolvable Machines 5(3), (2004), 251-257
15. Hastie T., Tibshirani R., and Friedman J., The Elements of Statistical Learning: Data Mining, Inference, and Prediction. Springer series in statistics. Springer, Berlin, 2001.
16. Rissanen, J., Modeling by shortest data description, Automatica 14, (1978) 465-471.
17. Vapnik, V. N. and Chervonenkis, A. Y, On the uniform convergence of relative frequencies of events to their probabilities. Theory Probab. Apl., (1971) 16, 264-280.
18. Vapnik, V.N, The Nature of Statistical Learning Theory, Springer-Verlag, Berlin, 1995.
19. Schaffer, C., Selecting a classification method by cross-validation, Machine Learning 13(1), (1993), 135-143.
20. Narasimhamurthy A, A framework for the analysis of majority voting. Lectures notes in Computer Science 2749, (2003), 268-274,
21. Narasimhamurthy A, Theoretical bounds for majority voting performance for a binary classification problem. PAMI, in press
22. Zou KH, Hall WJ, Shapiro DE. Smooth non-parametric receiver operating characteristic (ROC) curves for continuous diagnostic tests. Stat Med. 15, 16, (Oct, 1997) 2143-56.
23. Handley JA and McNeil BJ, The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology, 143(1), (1982 Apr), 29-36.
24. S. Gustafson., An Analysis of Diversity in Genetic Programming. Ph.D. Dissertation, School of Computer Science and Information Technology, University of Nottingham, Nottingham, U.K., 2004
25. E. Burke, S. Gustafson, and G. Kendall, A survey and analysis of diversity measures in genetic programming. In GECCO 2002: Proceedings of the Genetics and Evolutionary Computation Conference, (New York, 9-13 July 2002). Morgan Kaufmann, 716-723
26. Folino, C. Pizzuti, G. Spezzano L. Vanneschi, M. Tomassini, Diversity Analysis in Cellular and Multipopulation Genetic Programming in Proceedings of Congress on Evolutionary Computation 2003, (CEC'03) (Canberra 8-12 Dec 2003), IEEE Press, Piscataway, NJ, 305-311
27. Keinosuke Fukunaga, Introduction to Statistical Pattern Recognition, AcademicPress, London, 1990.
28. Moore, J.H., Parker, J.S., Olsen, N.J., and Aune, T., Symbolic discriminant analysis of microarray data in autoimmune disease. Genetic Epidemiology 23, (2002), 57-69.
29. Ritchie, M.D., Hahn, L.W., Roodi, N., Bailey, L.R., Dupont, W.D., Plummer, W.D., Parl, F.F. and Moore, J.H., Multifactor Dimensionality Reduction Reveals High-Order Interactions among Estrogen Metabolism Genes in Sporadic Breast Cancer. American Journal of Human Genetics, 69, (2001), 138-147.
30. MacLean CD, Wollesen EA, Worzel WP., Listening to Data: Tuning a Genetic Programming System. In: Genetic Programming Theory and Practice II. U-M O'Reilly, T Yu, R Riolo, WP Worzel (eds.), Springer Science+Business Media, Inc., NY, (2005), 245-62
31. Daida, J.M., What Makes a Problem GP-Hard? A Look at How Structure Affects Content. Genetic Programming Theory and Practice, eds. Riolo R.L. & Worzel W.P., Kluwer, Boston, MA, 2003, 99-118
32. Bellman, R. Adaptive Control Processes: A Guided Tour, Princeton University Press, NJ, (1961).
33. K. Sastry, U.-M. O'Reilly, D. E. Goldberg, Population Sizing for Genetic Programming Based Upon Decision Making in O'Reilly, U.M., et al. Genetic Programming Theory and Practice II. Kluwer Academic Publishers, Boston, MA (2004), 49-66
34. Roche Y, Pasquier D and Rambeaud JJ., Fibrinogen mediates bladder cancer cell migration in an ICAM-1-dependent pathway. Thromb Haemost, 89, (2003), 1089-97.
35. Ozer G, Altinel M, and Kocak B., Potential value of soluble intercellular adhesion molecule-1 in the serum of patients with bladder cancer. Urol Int, 70, (2003), 167-71.
36. Palumbo JS, Potter JM, and Kaplan LS., Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res, 62, (2002), 6966-72.
37. Rosette C, Roth RB, and Oeth P., Role of ICAM1 in invasion of human breast cancer cells. Carcinogenesis, 26, (2005), 943-50.
38. Jackson AM, Alexandrov AB, and Prescott S., Expression of adhesion molecules by bladder cancer cells: modulation by interferon-gamma and tumour necrosis factor-alpha. J Urol, 148, (1992), 1583-6.
39. Miele ME, Bennett CF, and Miller BE., Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides. Exp Cell Res, 214, (1994), 231-41.
40. Koyama S, Ebihara T, and Fukao K, Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma. J Cancer Res Clin Oncol, 118, (1992), 609-14.
41. Maruo Y, Gochi A, and Kaihara A., ICAM-1 expression and the soluble ICAM-1 level for evaluating the metastatic potential of gastric cancer. Int J Cancer, 100, (2002), 486-90.
42. O'Hanlon DM, Fitzsimons H, and Lynch J., Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer, 38, (2002), 2252-7.
43. Regidor PA, Callies R, and Regidor M, Expression of the cell adhesion molecules ICAM-1 and VCAM-1 in the cytosol of breast cancer tissue, benign breast tissue and corresponding sera. Eur J Gynaecol Oncol, 19, (1998), 377-83.
44. Santarosa M, Favaro D, Quaia M, et al., Expression and release of intercellular adhesion molecule-1 in renal-cancer patients. Int J Cancer, 62, (1995), 271-5.
45. Sun JJ, Zhou XD, Liu YK, et al, Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1. J Cancer Res Clin Oncol, 125, (1999), 28-34.
46. Tempia-Caliera AA, Horvath LZ, Zimmermann A, et al., Adhesion molecules in human pancreatic cancer. J Surg Oncol, 79, (2002), 93-100.
47. Yano S, Nokihara H, Yamamoto A, et al., Multifunctional interleukin-lbeta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci, 94, (2003), 244-52.
48. Roux PP and Blenis J, ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev, 68, (2004), 320-44.
49. Wang Q and Doerschuk CM, The p38 mitogen-activated protein kinase mediates cytoskeletal remodeling in pulmonary microvascular endothelial cells upon intracellular adhesion molecule-1 ligation. J Immunol, 166, (2001), 6877-84.
50. Zarubin THan J., Activation and signaling of the p38 MAP kinase pathway. Cell Res, 15, (2005), 11-8.
51. Huang X, Chen S, Xu L, et al., Genistein inhibits p38 map kinase activation, matrix metalloproteinase type 2, and cell invasion in human prostate epithelial cells. Cancer Res, 65, (2005), 3470-8.
52. Lin M, DiVito MM, Merajver SD, et al., Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin-1. Mol Cancer, 2004, 4 :21.
53. Ott I, Weigand B, Michl R, et al., Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Racl and the mitogen-activated protein kinase p38. Circulation, 111, (2005), 349-55.
54. Esteva FJ, Sahin AA, Smith TL, et al., Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma. Cancer, 100, (2004), 499-506.
55. Kim MS, Lee EJ, Kim HR, et al., p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells. Cancer Res, 63, (2003), 5454-61.
56. Shin I, Kim S, Song H, et al., H-Ras-specific activation of Rac-MKK3/6-p38 pathway: its critical role in invasion and migration of breast epithelial cells. J Biol Chem, 280, (2005), 14675-83.
57. Behren A, Binder K, Vucelic G, et al., The p38 SAPK pathway is required for Ha-ras induced in vitro invasion of NIH3T3 cells. Exp Cell Res, 303, (2005), 321-30.
58. Gakiopoulou-Givalou H, Nakopoulou L, Panayotopoulou EG, et al., Non-endothelial KDR/flk-1 expression is associated with increased survival of patients with urothelial bladder carcinomas. Histopathology, 43, (2003), 272-9.
59. Ferrer FA, Miller LJ, Lindquist R, et al., Expression of vascular endothelial growth factor receptors in human prostate cancer. Urology, 54, (1999), 567-72.